NCT00760370View on ClinicalTrials.gov

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Multiple MyelomaBreast Cancer
Interventions
DRUG

Zoledronic Acid

4 mg intravenous (iv), one treatment

Trial Locations (2)

5000

Odense University Hospital, Odense

7100

Vejle Hospital, Vejle

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Odense University Hospital

OTHER

collaborator

Novartis

INDUSTRY

lead

Vejle Hospital

OTHER